JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.92B |
| 2 |
iShares TIPS Bond ETF
TIP
|
+$1.54B |
| 3 |
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
|
+$1.2B |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.1B |
| 5 |
iShares MBS ETF
MBB
|
+$780M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.34B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.3B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.6B |
| 4 |
Texas Instruments
TXN
|
+$1.53B |
| 5 |
Tesla
TSLA
|
+$1.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.53% |
| 2 | Financials | 10.45% |
| 3 | Consumer Discretionary | 10.06% |
| 4 | Healthcare | 9.81% |
| 5 | Industrials | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4176
Alico
ALCO
$304M
| $522K | ﹤0.01% |
16,829
+10,953
| +186% | +$337K |
|
|
PFHD
4177
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $522K | ﹤0.01% |
33,857
+29,597
| +695% | +$431K |
|
4178
Global X Uranium ETF
URA
$6.31B
| $521K | ﹤0.01% |
34,022
+25,070
| +280% | +$307K |
|
4179
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.5B
| $520K | ﹤0.01% |
7,485
+901
| +14% | +$63K |
|
|
EVRI
4180
DELISTED
Everi Holdings
EVRI
| $519K | ﹤0.01% |
37,558
+5,946
| +19% | +$64.6K |
|
|
PAND
4181
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
| $517K | ﹤0.01% |
34,808
+32,021
| +1,149% | +$446K |
|
4182
RGC Resources
RGCO
$226M
| $516K | ﹤0.01% |
21,697
+15,247
| +236% | +$369K |
|
|
SI
4183
DELISTED
Silvergate Capital Corporation
SI
| $516K | ﹤0.01% |
6,938
-8,329
| -55% | -$275K |
|
4184
Occidental Petroleum Corp Warrants
OXY.WS
$33.7B
| – | – |
0
| – | – |
|
4185
Chemung Financial Corp
CHMG
$403M
| $513K | ﹤0.01% |
15,120
+6,762
| +81% | +$232K |
|
4186
Parke Bancorp
PKBK
$413M
| $512K | ﹤0.01% |
32,821
+22,860
| +229% | +$325K |
|
4187
Banco Macro
BMA
$5.14B
| $511K | ﹤0.01% |
32,838
+32,681
| +20,816% | +$485K |
|
4188
First Trust Rising Dividend Achievers ETF
RDVY
$25.8B
| $510K | ﹤0.01% |
12,765
-34
| -0.3% | -$1.24K |
|
|
EVFM
4189
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $510K | ﹤0.01% |
14,121
+11,945
| +549% | +$432K |
|
4190
Richmond Mutual Bancorp
RMBI
$256M
| $509K | ﹤0.01% |
37,274
+26,168
| +236% | +$321K |
|
4191
Nathan's Famous
NATH
$397M
| $508K | ﹤0.01% |
9,205
-1,016
| -10% | -$56.2K |
|
4192
Caledonia Mining Corp
CMCL
$439M
| $507K | ﹤0.01% |
31,906
+21,425
| +204% | +$354K |
|
4193
Frontline
FRO
$9.02B
| $507K | ﹤0.01% |
81,319
+5,962
| +8% | +$38.3K |
|
|
CZZ
4194
DELISTED
Cosan Limited
CZZ
| $506K | ﹤0.01% |
27,502
+14,561
| +113% | +$243K |
|
|
INDT
4195
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $505K | ﹤0.01% |
8,083
+6,593
| +442% | +$410K |
|
4196
Millicom
TIGO
$15.8B
| $503K | ﹤0.01% |
12,945
+7,423
| +134% | +$261K |
|
4197
Donegal Group Class A
DGICA
$696M
| $498K | ﹤0.01% |
35,468
+29,460
| +490% | +$424K |
|
4198
Harvard Bioscience
HBIO
$30.4M
| $498K | ﹤0.01% |
11,609
+7,737
| +200% | +$289K |
|
4199
KORU Medical Systems
KRMD
$154M
| $498K | ﹤0.01% |
82,670
+60,071
| +266% | +$336K |
|
|
ZEUS
4200
DELISTED
Olympic Steel
ZEUS
| $498K | ﹤0.01% |
37,369
+21,193
| +131% | +$285K |
|
Similar funds
JP Morgan Chase's Q4 2020 Portfolio in Review
As of Q4 2020, JP Morgan Chase held 6,220 positions worth $681B, up 14% from $595B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2020 filing shows 531 new, 2,858 increased, 1,755 reduced and 504 closed positions. Its largest new stake was Apartment Income REIT Corp.: 5,811,161 shares worth $223M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2020 buy was Apartment Income REIT Corp.: 5,811,161 shares worth $223M.
- JP Morgan Chase added most to iShares Core MSCI Emerging Markets ETF in Q4 2020, an estimated $3.92B increase.
- JP Morgan Chase's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.34B.
- JP Morgan Chase fully exited Bank of America Series L in Q4 2020, selling an estimated $117M.
- JP Morgan Chase's ten largest holdings make up 16% of its $681B portfolio in Q4 2020.
- JP Morgan Chase opened 531 new positions and closed 504 in Q4 2020.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $681B.
Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.